About Phlebot
Phlebot is a Healthcare company based in Lafayette (United States) founded in 2007. Automated blood sampling technology for personalized medicine is developed. Phlebot offers products and services including Phlebot and Tech Notes. Its focus areas include Traditional Medical Devices. Its legal entity is Phlebotics, Inc.
Company details
Developer of automated blood sampling technology for personalized medicine. This technology aims to improve intensive care medicine by enabling multiple blood samples to be collected over time with a single needle prick. The system is designed to reduce patient pain, improve safety and accuracy, and decrease labor costs associated with traditional blood collection methods. The technology is currently under development and not yet approved for human use.
- Headquarters Lafayette, United States
- SectorsHealthcare
- Email••••••••
- Website phlebot.com
- Social LinkedIn X Facebook
- Legal Name Phlebotics, Inc
- Latest Funding Round$20K (USD), Grant
Oct 2015
- InvestorsElevate Ventures
& 1 more
Products & Services of Phlebot
Phlebot offers a comprehensive portfolio of products and services, including Phlebot and Tech Notes.
The Phlebot is developed as a device for automated blood sampling that enables multiple collections with one insertion, thereby enhancing data accuracy and patient safety
Tech Notes are provided as informational materials that describe the underlying principles of automated blood sampling technology and its potential applications in healthcare
Funding Insights of Phlebot
- Total Rounds 1
- Last Round Grant — $20,000
- First Round $20,000
(Oct 2015)
- Investors Count 2
All 1 funding rounds of Phlebot with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2015 | $20,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Phlebot
Phlebot has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Elevate Ventures and Purdue Innovates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in diverse sectors by the firm. | elevateventures.com | Indianapolis, United States | ||
Support for technology commercialization and startup development is provided. | purduefoundry.com | West Lafayette, United States |
Investor details for Phlebot
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Phlebot
2 dated milestones of Phlebot across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Phlebot is founded.
- Funding First funding round of $20K.
Web traffic of Phlebot
Websites that share an audience with Phlebot (phlebot.com).
Websites whose visitors overlap most with Phlebot. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| irap.org | 100% | 69.4K | #534,475 | View details | |
thepathologist.com | thepathologist.com | 100% | #976,491 | – |
Top companies in Traditional Diagnostics & Medical Devices
3 companies that operate in the same segment as Phlebot (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Materials management solutions are provided for healthcare organizations. | 1892 | Chicago, Illinois, United States | USD 29.13 M | USD 19.48 B | 95,424 | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | Kalamazoo, Michigan, United States | ||||
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Phlebot
Phlebot was founded in 2007 and raised its 1st funding round 8 years after it was founded.
Phlebot is headquartered in Lafayette, United States. It is registered at Lafayette, Louisiana, United States.
Developer of automated blood sampling technology for personalized medicine. This technology aims to improve intensive care medicine by enabling multiple blood samples to be collected over time with a single needle prick. The system is designed to reduce patient pain, improve safety and accuracy, and decrease labor costs associated with traditional blood collection methods. The technology is currently under development and not yet approved for human use.
Phlebot offers Phlebot and Tech Notes.
Phlebot has 2 investors. Key investors include Elevate Ventures, and Purdue Innovates.
Phlebot operates through Phlebotics, Inc.